HomeMAAT • EPA
add
Maat Pharma SA
Previous close
€5.86
Day range
€5.92 - €5.96
Year range
€5.50 - €9.96
Market cap
96.05M EUR
Avg Volume
7.31K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 747.50K | 75.88% |
Operating expense | 8.04M | 37.95% |
Net income | -8.02M | -42.24% |
Net profit margin | -1.07K | 19.13% |
Earnings per share | — | — |
EBITDA | -7.78M | -37.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 20.15M | -16.99% |
Total assets | 38.50M | -10.32% |
Total liabilities | 28.16M | 25.37% |
Total equity | 10.34M | — |
Shares outstanding | 16.08M | — |
Price to book | 7.92 | — |
Return on assets | -50.88% | — |
Return on capital | -74.51% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -8.02M | -42.24% |
Cash from operations | -4.72M | -68.63% |
Cash from investing | -178.50K | -149.65% |
Cash from financing | -603.00K | 76.21% |
Net change in cash | -5.50M | -1.76% |
Free cash flow | -4.64M | -36.23% |
About
Founded
2014
Website
Employees
60